Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 51 to 75 of about 5928

Previous 25

Website Changes

04/28/2025

Brain Tumor Awareness Month Webinar Series

04/21/2025

Brain Tumor Awareness Month Webinar Series

04/21/2025

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy in Relapsed Brain Cancer Patients

04/21/2025

Discovery of FOXR2 activation in various brain tumors refines diagnosis to improve care

04/21/2025

Brain Tumor Awareness Month Webinar Series

04/14/2025

FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types

04/14/2025

VMX01 Plus Avelumab Is Safe and Shows Preliminary Clinical Activity in Recurrent Glioblastoma

04/11/2025

Musella Foundation Copay Program now closed to new and renewal applicants

04/11/2025

Promising Preliminary Results of Phase 1 Study

04/01/2025

Copayment assistance program is now open!

03/31/2025

UT Health San Antonio-led research discovers a way to slow or block recurrence in glioblastoma

03/31/2025

Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields

03/30/2025

Cancer Commons: Breaking Barriers in Cancer Care

03/17/2025

Hoops for Hannah: a March Madness Bracket Contest!

03/17/2025

Repurposed Cancer Drug Demonstrates Potential to Treat High-Grade Gliomas

03/17/2025

Studying Chemical Exposure and Brain Cancer Risk in Firefighters

03/17/2025

LAM561 as add-on may delay glioblastoma disease progression

03/10/2025

Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma

03/10/2025

Webinar tomorrow: The Gallium Maltolate Expanded Access Program: A Physician`s & Caregiver`s Perspective

03/03/2025

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

02/27/2025

Treatment strategy reprograms brain cancer cells, halting tumor growth

02/24/2025

Hydrogel and scalp/skin conductivities impact dose from tumor treating fields

02/12/2025

Musella Foundation Brain Tumor Treatment Copayment Assistance Program is now closed to new patients

02/10/2025

Targepeutics Receives Rare Pediatric Disease Designation from FDA for GB13

02/05/2025

Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications

Our privacy / cookie policy has changed.
Click HERE to read it!